We are live on ! Find out more
VTAK icon

Catheter Precision

10 hedge funds and large institutions have $1.95M invested in Catheter Precision in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

38% less funds holding

Funds holding: 1610 (-6)

49% less capital invested

Capital invested by funds: $3.84M → $1.95M (-$1.89M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
10
Holders Change
-6
Holders Change %
-37.5%
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
4
Reduced
Closed
9
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q2 2021 in Review

10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2021, worth a combined $1.95M — down 49% from $3.84M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VTAK and 3 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $457K. The largest seller was Royce & Associates, exiting entirely with an estimated $1.48M sold.

  • 10 institutional investors held Catheter Precision (VTAK) as of Q2 2021, down from 16 in Q1 2021.
  • Funds reported $1.95M of Catheter Precision stock for Q2 2021, down 49% quarter-over-quarter.
  • 3 funds opened new Catheter Precision positions in Q2 2021 and 9 closed out, a net change of -6 holders.
  • The largest Catheter Precision buyer in Q2 2021 was Vanguard Group, an estimated $457K added.
  • The largest Catheter Precision seller in Q2 2021 was Royce & Associates, an estimated $1.48M sold.

Based on aggregated 13F filings for Q2 2021.